PureHealth's Subsidiary Ardent Health Partners Makes NYSE Debut With $2.2B Market Valuation

This post was originally published on Forbes Middle East

PureHealth has concluded the IPO of its subsidiary, Ardent Health Partners, on NYSE, with a market valuation of $2.2 billion in its listing debut.